Authors: Rigamonti, AE Cavallera, G Bonomo, S Deghenghi, R Locatelli, V Cella, SG Muller, EE

Citation: Ae. Rigamonti et al., Growth hormone (GH) rebound rise following somatostatin infusion withdrawal: studies in dogs with the use of GH-releasing hormone and a GH-releasing peptide, EUR J ENDOC, 145(5), 2001, pp. 635-644

Authors: Rigamonti, AE Cella, SG Cavallera, GM Deghenghi, R Locatelli, V Pitsikas, N Muller, EE

Citation: Ae. Rigamonti et al., Contrasting effects of nitric oxide on food intake and GH secretion stimulated by a GH-releasing peptide, EUR J ENDOC, 144(2), 2001, pp. 155-162

Authors: Pitsikas, N Rigamonti, AE Cella, SG Locatelli, V Sala, M Muller, EE

Citation: N. Pitsikas et al., Effects of molsidomine on scopolamine-induced amnesia and hypermotility inthe rat, EUR J PHARM, 426(3), 2001, pp. 193-200

Authors: Rigamonti, AE Cella, SG Marazzi, N Muller, EE

Citation: Ae. Rigamonti et al., Six-week treatment with hexarelin in young dogs: evaluation of the GH responsiveness to acute hexarelin or GHRH administration, and of the orexigeniceffect of hexarelin, EUR J ENDOC, 141(3), 1999, pp. 313-320

Authors: Rigamonti, AE Cella, SG Marazzi, N Muller, EE

Citation: Ae. Rigamonti et al., Nitric oxide modulation of the growth hormone-releasing activity of Hexarelin in young and old dogs, METABOLISM, 48(2), 1999, pp. 176-182

Authors: Cappa, M Rigamonti, AE Bizzarri, C Porzio, O Civolani, P Cella, SG Loche, S Muller, EE

Citation: M. Cappa et al., Commentary - Somatostatin infusion withdrawal: Studies in normal children and in children with growth hormone deficiency, J CLIN END, 84(12), 1999, pp. 4426-4430